EASL Podcasts
The EASL Podcast collection brings together Talk Liver to Me, EASL’s exclusive original podcast, alongside educational audio content adapted from EASL Studio, DeepDive webinars, and Policy Dialogues.
Stay informed with expert insights, practical discussions, and the latest knowledge in hepatology — anytime, anywhere.
Episodes
152 episodes
Talk Liver To Me - Liver Transplantation: Rise of the machines
In this episode, we discuss the first pig-to-human liver xenotransplantation and the breakthroughs behind the revival of xenotransplantation, examining its potential and remaining challenges. We also explore the accelerating field of machine pe...
Talk Liver To Me - Spontaneous Bacterial Peritonitis: Time to Rethink the Rules?
Spontaneous bacterial peritonitis (SBP) remains a major complication of cirrhosis - but rising antimicrobial resistance and emerging data are challenging long-standing practices.In this episode, we review current evidence on primary and ...
EASL DeepDive: Key Updates in the EASL Clinical Practice Guidelines on extrahepatic Cholangiocarcinoma (eCCA)
In this EASL DeepDive webinar, the expert panel presents and explains the key studies behind the latest recommendations included in the EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma.Learning Ob...
Talk Liver To Me - World Liver Day: Making Lifestyle Change Possible
This episode explores the role of lifestyle in preventing and managing liver disease, including MASLD/MASH. Our experts discuss the impact of diet and physical activity, why lifestyle change can be difficult to start and sustain, and why small,...
EASL DeepDive: Key Changes in the New EASL HBV Guidelines
In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of hepatitis B virus infection, published in the "Journal of Hepatology" in 2025.Learning objectives
EASL DeepDive: EASL Clinical Practice Guidelines on the management of autoimmune hepatitis
In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of autoimmune hepatitis, published in the "Journal of Hepatology" in 2025.Learning objectivesSe...
EASL DeepDive: The Pursuit of a Cure: HCC Management Strategies
Hepatocellular carcinoma (HCC) is responsible for 75% of all primary liver cancers and is the third most prevalent cause of cancer death worldwide, with 900,000 new cases diagnosed each year. Many patients are diagnosed at an advanced stage, ma...
Talk Liver To Me - Baveno VIII: The takeaways you shouldn’t miss
In this episode our speakers share their immediate impressions and break down the key highlights shaping the management of portal hypertension and advanced liver disease. What has truly changed in practice? Where was consensus reached and where...
Talk Liver To Me - Updated BCLC Guidelines for HCC: Protocolised or Patient-Centred Care?
This episode unpacks the updated BCLC guidelines for hepatocellular carcinoma management. Experts discuss the strengths and limitations of the BCLC model in an era of rapidly evolving systemic therapies and personalised care, sharing real-world...
Talk Liver To Me - When Cure isn’t the only goal: Palliative Care in Advanced Liver Disease
As deaths from advanced chronic liver disease rise, many patients never receive timely palliative care.In this episode, we explore why early, holistic support is essential in advanced liver disease and HCC, and unpack key recommendations...
Talk Liver To Me - MetALD in Practice: Does it Change How We Treat Patients?
This episode explores whether MetALD is a meaningful clinical entity or an unnecessary complication. Experts discuss the overlap between metabolic dysfunction and alcohol use, the challenges of applying the MetALD definition in practice, and it...
Talk Liver To Me - From imposter syndrome to influence: Women shaping hepatology
EASL’s Secretary General and Vice Secretary General share an open conversation on the challenges and opportunities for women in hepatology. The episode explores the role of mentorship across career stages and reflects on the journey toward EASL...
Talk Liver To Me - Hepatology Ward Rounds: East Meets West
In collaboration with the Indian National Association for the Study of the Liver (INASL), hepatologists from South Asia and North America/Europe take listeners inside their liver wards to explore how regional context shapes acute liver care. Fr...
EASL Studio Podcast: Collaborating across disciplines to find the best solution for people living with PBC
This EASL Studio episode brings key insights from the 2025 EASL–AASLD Consensus Conference on Primary Biliary Cholangitis (PBC).Experts explore the use of surrogate endpoints, the challenges in current trial design and regulation, the va...
EASL Studio Podcast: What Can Be Done to Safeguard Young Adults from SLD?
How can we protect young adults from steatotic liver disease (SLD)? This episode explores the burden of MASLD, MetALD, and ALD in Europe, the synergistic effects of alcohol and metabolic risk factors, and why the younger population is especiall...
EASL Studio Podcast: Decoding AASLD The Liver Meeting: Trends Shaping Hepatology
What were the key takeaways from this year’s AASLD The Liver Meeting? In this episode, experts unpack the most impactful studies, clinical insights, and emerging trends shaping the future of hepatology. From liver cancer breakthroughs to MASLD,...
EASL Studio Podcast: Rifaximin for Hepatic Encephalopathy: Balancacing Benefits and Risks in the Era of Antimicrobial Resistance
For World Antimicrobial Awareness Week 2025 (“Act Now: Protect Our Present, Secure Our Future”), this EASL Studio explores the balance between rifaximin’s benefits in hepatic encephalopathy and the global challenge of antimicrobial res...
EASL Studio Podcast: Behind the Decision: How Can You Maximize Your Chances of Publication in JHEP Reports?
Ever wondered what happens to your manuscript after submission? In this episode, the JHEP Reports editorial team takes you behind the scenes: from first triage to reviewer selection, smart moves vs. red flags, and how final decisions are made. ...
EASL Studio Podcast: Are we finally entering an era of effective treatment for PSC?
After years of limited progress, recent trials hint at a changing landscape for primary sclerosing cholangitis (PSC). In this episode, experts review emerging data and explore whether we’re approaching a new era of effective treatment. How shou...
EASL Studio Podcast: Does it really matter whether we call it ACLF or acute decompensation?
This episode questions whether assigning the label “ACLF” to a deteriorating patient truly alters clinical decisions, or if focusing on the specifics of organ failure and reversibility is more useful. Experts debate the real-world utility of pr...
EASL Studio Podcast: The Clinical Blind Spot: Are We Neglecting Alcohol?
This EASL Studio explores the discrepancy between the huge burden of patients hospitalised with, and dying from, alcohol-related liver disease (ALD) or MetALD, versus the same disease’s near non-existence from population data. The panel will di...
EASL Studio Podcast: Hepatitis C, Re-infection or Failure of Treatment in People Engaging in High Risk Practices – Do These Labels Matter in 2025?
What do we call it when someone with high-risk practices becomes viraemic again after treatment? In this episode, experts discuss the challenges of managing Hepatitis C in people who inject drugs (PWID) and other high-risk groups. Topics includ...
EASL Studio Podcast: What Matters Most? The questions every hepatologist should ask their patients
In hepatology, effective care goes beyond diagnostics and treatment. This episode explores the crucial questions hepatologists should ask to truly understand their patients’ needs, values, and priorities. By focusing on communication and patien...
EASL DeepDive: Diagnosis, non-invasive screening and risk stratification of MASLD cases
This first session in a two-part EASL DeepDive series on the 2024 EASL-EASD-EASO MASLD Clinical Practice Guidelines will provide a detailed examination of the recommendations concerning diagnosis, non-invasive assessment, and risk stratificatio...
%20(2).png)
EASL Studio Podcast: EASL CPGs on Vascular Liver Diseases: What’s New?
This episode addresses key challenges in vascular complications of liver disease, including the management of portal vein thrombosis (PVT) in patients with and without cirrhosis. Experts will explore controversies surrounding long-term anticoag...
